Taxosted 120mg Injection

About

Taxosted 120mg Injection is an antineoplastic agent belonging to the taxane class of chemotherapy drugs. It functions by interfering with the normal function of microtubules, which are essential structures for cell division. By stabilizing microtubules and preventing their depolymerization, Taxosted disrupts the dynamic equilibrium required for cell replication, leading to mitotic arrest and subsequent apoptosis in rapidly proliferating cancer cells. This mechanism makes it highly effective against various solid tumors. It is typically administered intravenously under strict medical supervision as part of a comprehensive cancer treatment regimen, often in combination with other therapeutic agents.

Uses

• Treatment of metastatic breast cancer
• Management of non-small cell lung cancer
• Therapy for advanced prostate cancer
• Used in certain gastric adenocarcinomas

Directions For Use

Administered intravenously by a qualified healthcare professional. Dosage and frequency are determined by the physician based on the patient's condition.

Benefits

• Inhibits cancer cell growth effectively
• Induces programmed cell death in tumor cells
• Effective against a broad spectrum of solid tumors
• Can improve progression-free survival rates
• Often used as part of combination chemotherapy regimens
• Well-established efficacy in oncology practice

Side Effects

• Myelosuppression (low white blood cell count)
• Peripheral neuropathy (numbness, tingling)
• Alopecia (hair loss)
• Nausea and vomiting
• Fatigue and weakness
• Fluid retention (edema)
• Hypersensitivity reactions (allergic reactions)
• Mucositis (inflammation of mucous membranes)
• Arthralgia (joint pain) and myalgia (muscle pain)
• Diarrhea
• Nail changes
• Skin reactions (rash, redness)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption due to potential for increased liver toxicity and gastrointestinal irritation.
• Pregnancy - Contraindicated. Known to cause severe fetal harm. Effective contraception is mandatory during treatment.
• Breastfeeding - Not recommended. The drug may be excreted in breast milk and could cause serious adverse effects in the infant.
• Liver - Use with caution; dose adjustments may be necessary in patients with hepatic impairment due to altered metabolism and increased toxicity risk.
• Kidney - Use with caution; dose adjustment may be considered in severe renal impairment, though primarily hepatically metabolized.
• Lung - Monitor for pulmonary toxicity, such as interstitial pneumonitis, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.